Elbasvir/Grazoprevir Plus Sofosbuvir in Treatment-Naive and Treatment-Experienced Cirrhotic Patients with Hepatitis C Virus Genotype 3 Infection Treated for 8, 12 or 16 Weeks: Final Results of the C-ISLE Study

B Haber, GR Foster, K Agarwal, ME Cramp, S Moreea, S Barclay, J Collier, AS Brown, SD Ryder, A Ustianowski, D Forton, R Fox, F Gordon, W Rosenberg, DJ Mutimer, J Du, CL Gilbert, M Robertson, E Barr

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - Apr 2017

Cite this